Both in Pharmaceuticals
AbCellera Biologics vs Dianthus Therapeutics
Over the past year ABCL returned +204.3% and DNTH returned +120.4%; their daily moves had a correlation of 0.30.
ABCL +204.3% DNTH +120.4%Growth of $1, one year, split-adjusted
| Metric | ABCL | DNTH |
|---|---|---|
| Price | $14.82 | $87.16 |
| Market cap | $4.80B | $4.88B |
| Today | +6.47% | −0.76% |
| 1 month | +30.6% | −17.6% |
| 6 months | +351.8% | +9.7% |
| Year to date | +333.3% | +111.5% |
| 1 year | +212.7% | +137.4% |
| Revenue growth (YoY) | −76.3% | +294.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1368.6% | −6598.6% |
| P/E (TTM) | — | — |
| Price / sales | 72.6× | 2,560.5× |
| Net cash | $540.1M | $886.8M |
| Dividend yield | — | — |
| Volatility (60d) | 99.2% | 49.0% |
| Short % of float | 15.9% | 17.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).